Investment ThemesDetailed Quotes
Gene Editing Watchlist

Gene Editing is the ability to make highly specific changes in the DNA sequence of a living organism, essentially customizing its genetic makeup. It demonstrates great potential in gene research, gene therapy and genetic improvement. The Gene Editing concept includes major US-listed companies whose businesses are involved in gene editing.

  • 1424.128
  • +11.687+0.83%
Close Feb 28 16:00 ET
1433.707High1407.703Low
Constituent Stocks: 10Top Rising: BLUE+7.37%
Intraday
  • 5D
  • Daily
  • Weekly
  • Monthly
  • 1Q
  • 1Y
Constituent Stocks
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
WatchlistPaper Trade
BLUEbluebird bio
4.0800.280+7.37%272.28K1.08M3.7603.8004.0803.72039.74M39.48M9.74M9.68M0.00%-43.72%-48.42%-49.63%-64.13%-85.32%-51.08%--2.81%LossLoss9.47%Biotechnology
SGMOSangamo Therapeutics
1.0200.063+6.57%3.37M3.38M0.9580.9571.0500.910212.82M206.85M208.65M202.80M-4.67%-12.82%-17.07%-54.87%+35.76%-12.07%0.00%--1.66%LossLoss14.62%Biotechnology
EDITEditas Medicine
1.9200.090+4.92%3.73M6.83M1.7801.8301.9201.720158.49M157.87M82.55M82.22M0.00%+56.10%+40.15%-14.29%-44.99%-80.91%+51.18%--4.53%LossLoss10.93%Biotechnology
VRTXVertex Pharmaceuticals
479.7905.290+1.11%2.47M1.18B479.900474.500484.980474.010123.21B122.77B256.79M255.89M-0.92%+3.72%+9.44%+2.49%+2.39%+14.03%+19.14%--0.97%LossLoss2.31%Biotechnology
CRBUCaribou Biosciences
1.1700.010+0.86%1.31M1.50M1.1701.1601.1901.110105.95M91.44M90.55M78.16M-10.69%-10.69%-10.69%-46.58%-36.07%-85.21%-26.42%--1.67%LossLoss6.90%Biotechnology
CRSPCRISPR Therapeutics
43.9200.300+0.69%1.66M72.48M42.62043.62044.51042.0003.77B3.69B85.77M83.93M-8.33%+0.99%+4.47%-14.17%-2.94%-47.85%+11.59%--1.98%LossLoss5.75%Biotechnology
AAgilent Technologies
127.9200.840+0.66%2.85M362.42M128.200127.080129.510125.95536.49B36.37B285.23M284.29M-5.50%-6.25%-15.50%-7.11%-7.23%-6.22%-4.78%0.75%1.00%29.3428.882.80%Diagnostics & Research
BEAMBeam Therapeutics
26.340-0.770-2.84%1.47M38.86M26.77027.11027.29025.7702.20B1.84B83.69M69.77M-13.44%-7.93%-3.45%-3.76%+8.93%-33.30%+6.21%--2.11%LossLoss5.61%Biotechnology
APLSApellis Pharmaceuticals
25.150-0.850-3.27%2.96M73.98M26.00026.00026.05024.3303.16B2.12B125.52M84.21M-8.61%-8.41%-17.24%-25.88%-35.99%-59.42%-21.18%--3.51%LossLoss6.62%Biotechnology
NTLAIntellia Therapeutics
10.090-0.770-7.09%4.58M45.54M10.27010.86010.3409.5151.04B991.04M103.52M98.22M-17.09%+4.67%-4.00%-35.40%-51.79%-68.59%-13.46%--4.66%LossLoss7.60%Biotechnology

News

Comments

Read more